Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,030.00
-9.00 (-0.87%)
Mar 10, 2026, 12:40 PM KST

Enzychem Lifesciences Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
80,659113,768154,649139,497457,391869,255
Upgrade
Market Cap Growth
-32.06%-26.43%10.86%-69.50%-47.38%57.11%
Upgrade
Enterprise Value
-24,2903,16216,479-29,937400,389835,243
Upgrade
Last Close Price
1039.001425.001818.001655.009150.0013885.04
Upgrade
PS Ratio
1.121.472.035.2419.9133.67
Upgrade
PB Ratio
0.540.710.800.696.1311.99
Upgrade
P/TBV Ratio
0.560.730.820.706.7312.33
Upgrade
EV/Sales Ratio
-0.040.22-17.4332.35
Upgrade
Debt / Equity Ratio
0.030.030.030.190.700.59
Upgrade
Net Debt / Equity Ratio
-0.71-0.69-0.68-0.77-0.57-0.65
Upgrade
Net Debt / EBITDA Ratio
7.258.6911.7412.642.292.78
Upgrade
Net Debt / FCF Ratio
37.87124.9710.536.961.752.81
Upgrade
Asset Turnover
0.400.390.330.140.180.25
Upgrade
Inventory Turnover
5.785.405.802.672.592.82
Upgrade
Quick Ratio
14.8511.0410.634.791.879.72
Upgrade
Current Ratio
17.5613.0312.335.212.0510.73
Upgrade
Return on Equity (ROE)
-14.74%-12.40%-4.74%-18.16%-37.87%-23.90%
Upgrade
Return on Assets (ROA)
-6.25%-5.21%-4.01%-4.81%-10.10%-11.44%
Upgrade
Return on Capital Employed (ROCE)
-11.20%-9.60%-7.50%-7.10%-26.10%-16.80%
Upgrade
Earnings Yield
-30.14%-19.43%-6.03%-17.99%-6.09%-2.01%
Upgrade
FCF Yield
-3.48%-0.79%-8.09%-15.97%-5.34%-1.94%
Upgrade
Buyback Yield / Dilution
5.68%3.50%-7.75%-56.10%-3.93%-3.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.